Coherus Biosciences | Costo Del Venduto

Prezzo Delle Azioni
2.15
Cambio Giornaliero
0.09 4.13%
Mensile
30.00%
Annuale
93.24%
Q1 Previsione
2.39




Costo Del Venduto Cambiamento Data
AbbVie USD 4.55B 757M 2025-12
Acadia Pharmaceuticals USD 21.65M 913K 2025-09
Akebia Therapeutics USD 8.13M 2.41M 2025-03
ALKERMES USD 51.59M 2.13M 2025-09
Alnylam Pharmaceuticals USD 200.15M 57.2M 2025-09
Amarin USD 16.89M 18.51M 2025-03
Amgen USD 1.79B 128M 2025-12
Baxter International USD 1.88B 66M 2025-09
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 144.93M 10M 2025-09
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Coherus Biosciences USD 2.65M 31.2M 2025-03
Eli Lilly USD 3.37B 363.7M 2025-12
Fujifilm JPY 509.85B 19.73B 2025-12
Gilead Sciences USD 1.57B 68M 2025-09
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Merck USD 3.32B 531M 2025-12
Myriad Genetics USD 61.9M 600K 2025-09
Pacira USD 48.6M 6.59M 2025-09
Perrigo USD 666.2M 27.2M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 23.32M 7.83M 2025-09
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Sarepta Therapeutics USD 151.45M 1.77M 2025-09
Teva Pharmaceutical Industries USD 2.06B 120M 2025-12
Vertex Pharmaceuticals USD 414.8M 7.3M 2025-09
Xencor USD 61.66M 50.95M 2025-06
Zoetis USD 683M 3M 2025-09


Coherus Biosciences Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.